APA (7th ed.) Citation

JS, D., M, C., G, L., L, L., C, B., O, B., . . . A, N. (2024). Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 177, 116988. https://doi.org/10.1016/j.biopha.2024.116988

Chicago Style (17th ed.) Citation

JS, Driouich, et al. "Preclinical in Vivo Assessment of the Activity of AZD7442 Anti-SARS-CoV-2 Monoclonal Antibodies Against Omicron Sublineages." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 177 (2024): 116988. https://doi.org/10.1016/j.biopha.2024.116988.

MLA (9th ed.) Citation

JS, Driouich, et al. "Preclinical in Vivo Assessment of the Activity of AZD7442 Anti-SARS-CoV-2 Monoclonal Antibodies Against Omicron Sublineages." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 177, 2024, p. 116988, https://doi.org/10.1016/j.biopha.2024.116988.